Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazide Based Treatment Regimen With Optional Addition of Amlodipine [Phase 3]
Phase 3 clinical trial comparing the long-term efficacy and safety of an aliskiren-based regimen against a hydrochlorothiazide-based regimen…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren 150mg, 300mg, and 600mg to Placebo in Patients With High Blood Pressure. [Phase 3]
A Phase 3 dose-ranging trial evaluated the safety and efficacy of aliskiren at 150 mg, 300 mg, and 600 mg versus placebo in patients with hy…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren in Patients With High Blood Pressure [Phase 3]
A Phase 3 dose-ranging trial evaluating the safety and efficacy of aliskiren for hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazidebased Treatment Regimen With Optional Addition of Amlodipine [Phase 3]
A Phase 3 trial comparing long-term efficacy and safety of an aliskiren-based regimen with a hydrochlorothiazide-based regimen, with optiona…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: An Enhanced Medication Monitoring Program [Phase 1]
Phase 1 clinical trial update on an enhanced medication monitoring program addressing hypertension and medication adherence.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension [Phase 4]
Phase 4 trial evaluating whether combining amlodipine besylate with benazepril is more effective than amlodipine alone for severe hypertensi…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: To Find Out Whether Valsartan With or Without Other Blood Pressure Medications Would Improve the Ability of the Heart to Fill and Empty, and the Ability of the Heart Muscle to Relax Adequately in People With High Blood Pressure. [Phase 4]
A Phase 4 trial by Novartis evaluated whether valsartan, with or without other blood pressure medications, improves the heart's filling, pum…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Effects of Amlodipine/Benazepril in the Hypertensive African-American Population With Type 2 Diabetes Mellitus [Phase 4]
Phase 4 clinical trial update evaluating the efficacy of the amlodipine/benazepril combination in hypertensive African-American patients wit…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe Hypertension [Phase 3]
Phase 3 trial evaluating a valsartan/Hydrochlorothiazide combination for severe hypertension has completed. The update notes completion but …
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Diva - The Effects Of 12 Weeks Of Treatment With High Dose Valsartan (320 Mg) To Amlodipine On Endothelial Function In Hypertensive Subjects With The Metabolic Syndrome [Phase 4]
Phase 4 trial update evaluating the effects of 12 weeks of high-dose valsartan (320 mg) added to amlodipine on endothelial function in hyper…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Long Term Safety of Aliskiren Alone or With the Optional Addition of Hydrochlorothiazide in Patients With Essential Hypertension [Phase 3]
A long-term safety study of aliskiren, alone or with hydrochlorothiazide, in essential hypertension has completed Phase 3 testing.
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes Mellitus [Phase 4]
Phase 4 trial evaluating whether valsartan reduces proteinuria in patients with hypertension and type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension [Phase 3]
Phase 3 clinical trial comparing valsartan alone to valsartan plus hydrochlorothiazide in adults with hypertension has completed. The sponso…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Efficacy and Safety of Fluvastatin or Valsartan and Their Combination in Dyslipidemic Patients With Hypertension and Endothelial Dysfunction [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of fluvastatin, valsartan, and their combination in dyslipidemic patients with hyp…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: A Study Of Valsartan Used To Treat Hypertension For Up To 56 Weeks In Children Ages 1 - 5 Years Who Have Hypertension [Phase 3]
A Phase 3 trial evaluating valsartan for treating hypertension in children aged 1 to 5 years has completed (up to 56 weeks of treatment).
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Comparison of Two Treatment Strategies in Hypertensive Patients [Phase 4]
A Phase 4 clinical trial comparing two hypertension treatment strategies sponsored by Novartis has completed.
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: 8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension [Phase 3]
A Phase 3 clinical trial update evaluating safety and efficacy of various combinations of valsartan, hydrochlorothiazide, and amlodipine in …
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in Hypertension [Phase 4]
This update notes the completion of a Phase 4 trial comparing valsartan plus amlodipine versus amlodipine alone for hypertension.
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Effects of Blood Pressure Reduction on High Sensitivity C-Reactive Protein (hsCRP) [Phase 4]
Phase 4 trial update investigating whether reducing blood pressure affects high-sensitivity C-reactive protein (hsCRP) levels in patients wi…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone [Phase 3]
Phase 3 trial update evaluating the valsartan/hydrochlorothiazide combination in hypertensive patients not adequately controlled on valsarta…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Antialbuminuric Effects of Valsartan and Lisinopril [Phase 4]
Phase 4 trial update evaluating the antialbuminuric effects of valsartan and lisinopril in hypertension and early diabetic nephropathy; the …
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria. [Phase 4]
A Phase 4 trial comparing valsartan/hydrochlorothiazide to amlodipine in patients with hypertension, diabetes, and albuminuria has completed…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: A Study to Describe Vascular and Renal Effects and Safety of Valsartan in Patients With High Blood Pressure [Phase 4]
Phase 4 study update evaluating vascular and renal effects and overall safety of valsartan in adults with hypertension; the trial status is …
-
CLINICAL_TRIALS trial_result · 2011-11-02Clinical Trial Update: Survey to Assess Why People Are Not Responding to Treatment in Hypertension
A Bayer-sponsored clinical trial update summarizes a survey exploring why some patients with hypertension do not respond to treatment. The s…
-
CLINICAL_TRIALS trial_result · 2011-10-31Clinical Trial Update: Device Based Therapy in Hypertension Extension Trial [NA]
CVRx's device-based therapy extension trial for hypertension has completed.